Related Subjects:
|Wolff-Parkinson White syndrome (WPW) AVRT
|Lown Ganong Levine Syndrome AVRT
|Supraventricular Tachycardia (SVT)
|Atrioventricular Nodal Reentrant Tachycardia AVNRT
|Atrial Flutter
|Atrial Fibrillation
|Sinus Tachycardia
|Sinus Arrhythmia
|Multifocal Atrial Tachycardia
|Resuscitation - Adult Tachycardia Algorithm
โก Patients often feel an intense, unpleasant sensation for 20โ30 seconds after adenosine - this is always transient.
โ
Reassure them it will quickly pass.
๐ซ Do not use in asthmatics (risk of severe bronchospasm).
๐ About
- Purine nucleotide used to treat supraventricular tachycardias (SVTs).
- Adenosine receptor agonist (mainly A1 receptors in the heart).
- Always check the BNF link here.
โ๏ธ Mode of Action
- Activates A1 purinergic receptors at the SAN and AVN.
- Inhibits adenylate cyclase โ โcAMP โ increased outward K+ flux.
- Causes hyperpolarisation of nodal tissue โ slows AV nodal conduction.
๐ซ Actions
- Produces transient AV block, bradycardia, or even brief asystole.
- Does not cardiovert AF or flutter, but may transiently slow AV conduction and unmask flutter waves.
- Also acts as a vasodilator โ flushing, hypotension.
- Very short half-life (<10 seconds) โ must reach the AV node before metabolism.
๐ Dose & Administration โ Adenosine (verify with BNF/datasheet)
| Indication / Context |
Details |
โก Sensitised patients
(on dipyridamole, carbamazepine, post-transplant, or via central line) |
Adenosine
โข Dose: 1โ3 mg stat
โข Route: Rapid IV bolus into large vein
โข Flush: Immediately with 20 mL 0.9% NaCl
|
| โก๏ธ Standard first dose |
Adenosine
โข Dose: 6 mg stat
โข Route: Rapid IV bolus + 20 mL NS flush
โข Note: If ineffective, escalate
|
| ๐ If 6 mg ineffective |
Adenosine
โข Dose: 12 mg stat (may repeat once)
โข Route: Rapid IV bolus + 20 mL NS flush
|
| ๐ก Administration Notes |
โข Give via large peripheral or central vein
โข Follow immediately with 20 mL NS flush
โข Warn patient of transient unpleasant effects (flushing, chest pressure, breathlessness, sense of doom)
|
๐ฉบ Indications
- Termination of paroxysmal SVTs (AVNRT, AVRT).
- Diagnostic aid: can unmask atrial flutter/fibrillation waves.
- Used in myocardial perfusion imaging (diagnostic pharmacology).
๐ซ Contraindications
- Asthma or severe COPD (risk of bronchospasm) โ consider verapamil instead.
- Long QT syndrome, sick sinus syndrome, 2nd/3rd-degree AV block (unless paced).
- Heart transplant patients: extremely sensitive (use lower dose).
โ ๏ธ Side Effects
- Transient: chest discomfort, flushing, dyspnoea, nausea, sense of impending doom.
- Bradyarrhythmia, sinus pause, complete heart block (short-lived).
- Bronchospasm in susceptible patients.
๐ Interactions
- Dipyridamole: potentiates effect โ use reduced starting dose (as low as 1 mg).
- Theophylline/aminophylline: antagonise adenosine โ reduced effect.
- Carbamazepine: enhances AV block โ use lower doses.
๐ References